2m 2m 2m 2m 2m 2m 2m
TAYSHA GENE THER (TSHA)
NASDAQ
$5.41+$0.03 (+0.56%)
Price as of Jul 14, 2026 8:04 AM EDT- $1.5BMarket Cap
- 103.79%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$5.41+$0.03 (+0.56%)
TSHA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.38 | ||
Change | -$0.96 (-15.14%) | ||
Open | $6.29 | ||
High | $6.29 | ||
Low | $5.32 | ||
Previous Close | $6.34 | ||
Volume | 6,443,872 | ||
30-Day Average Volume | 4,359,496 | ||
1-Week Change | -15.67% | ||
1-Month Change | -5.78% | ||
1-Year Change | 103.79% | ||
3-Year Change | 668.57% | ||
5-Year Change | -73.73% | ||
Fundamentals | |||
Shares Outstanding | 287.4M | ||
Total Assets | $300.4M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$42.4M | ||
Free Cash Flow | -$40.9M | ||
EBIT | -$42.4M | ||
EBITDA | -$42.1M | ||
Net Working Capital | $262.2M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -45 | ||
PEG | 1 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue